Ferdinando Nicoletti, Ph.D/MD - Publications

Pharmacology Sapienza University of Rome, Roma, Lazio, Italy 

96 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Morley-Fletcher S, Mairesse J, Van Camp G, Reynaert ML, Gatta E, Marrocco J, Bouwalerh H, Nicoletti F, Maccari S. Perinatal Stress Programs Sex Differences in the Behavioral and Molecular Chronobiological Profile of Rats Maintained Under a 12-h Light-Dark Cycle. Frontiers in Molecular Neuroscience. 12: 89. PMID 31118884 DOI: 10.3389/fnmol.2019.00089  0.4
2019 Nicoletti F, Orlando R, Di Menna L, Cannella M, Notartomaso S, Mascio G, Iacovelli L, Matrisciano F, Fazio F, Caraci F, Copani A, Battaglia G, Bruno V. Targeting mGlu Receptors for Optimization of Antipsychotic Activity and Disease-Modifying Effect in Schizophrenia. Frontiers in Psychiatry. 10: 49. PMID 30890967 DOI: 10.3389/fpsyt.2019.00049  0.56
2018 Matrisciano F, Dong E, Nicoletti F, Guidotti A. Epigenetic Alterations in Prenatal Stress Mice as an Endophenotype Model for Schizophrenia: Role of Metabotropic Glutamate 2/3 Receptors. Frontiers in Molecular Neuroscience. 11: 423. PMID 30564095 DOI: 10.3389/fnmol.2018.00423  0.6
2018 Gatta E, Mairesse J, Deruyter L, Marrocco J, Van Camp G, Bouwalerh H, Lo Guidice JM, Morley-Fletcher S, Nicoletti F, Maccari S. Reduced maternal behavior caused by gestational stress is predictive of life span changes in risk-taking behavior and gene expression due to altering of the stress/anti-stress balance. Neurotoxicology. 66: 138-149. PMID 29630914 DOI: 10.1016/j.neuro.2018.04.005  0.4
2017 Di Menna L, Joffe ME, Iacovelli L, Orlando R, Lindsley CW, Mairesse J, Gressèns P, Cannella M, Caraci F, Copani A, Bruno V, Battaglia G, Conn PJ, Nicoletti F. Functional partnership between mGlu3 and mGlu5 metabotropic glutamate receptors in the central nervous system. Neuropharmacology. PMID 29079293 DOI: 10.1016/j.neuropharm.2017.10.026  0.32
2016 Panaccione I, Iacovelli L, Nuzzo LD, Nardecchia F, Mauro G, Janiri D, Blasi A, Sani G, Nicoletti F, Orlando R. Paradoxical sleep deprivation in rats causes a selective reduction in the expression of type-2 metabotropic glutamate receptors in the hippocampus. Pharmacological Research. PMID 27890550 DOI: 10.1016/j.phrs.2016.11.029  0.6
2016 McCubrey JA, Rakus D, Gizak A, Steelman LS, Abrams SL, Lertpiriyapong K, Fitzgerald TL, Yang LV, Montalto G, Cervello M, Libra M, Nicoletti F, Scalisi A, Torino F, Fenga C, et al. Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity-Diverse effects on cell growth, metabolism and cancer. Biochimica Et Biophysica Acta. PMID 27612668 DOI: 10.1016/j.bbamcr.2016.09.004  0.6
2016 Bruno V, Caraci F, Copani A, Matrisciano F, Nicoletti F, Battaglia G. The impact of metabotropic glutamate receptors into active neurodegenerative processes: A "dark side" in the development of new symptomatic treatments for neurologic and psychiatric disorders. Neuropharmacology. PMID 27140693 DOI: 10.1016/j.neuropharm.2016.04.044  0.56
2016 Steelman LS, Martelli AM, Cocco L, Libra M, Nicoletti F, Abrams SL, McCubrey JA. The Therapeutic Potential of mTOR Inhibitors in Breast Cancer. British Journal of Clinical Pharmacology. PMID 27059645 DOI: 10.1111/bcp.12958  0.6
2016 Gatta E, Lefebvre T, Gaetani S, Santos MD, Marrocco J, Mir AM, Cassano T, Maccari S, Nicoletti F, Mairesse J. Evidence for an imbalance between tau O-GlcNAcylation and phosphorylation in the hippocampus of a mouse model of Alzheimer's disease. Pharmacological Research. PMID 26816085 DOI: 10.1016/j.phrs.2016.01.006  0.6
2016 Matrisciano F, Panaccione I, Grayson DR, Nicoletti F, Guidotti A. Metabotropic Glutamate 2/3 Receptors and Epigenetic Modifications in Psychotic Disorders: A Review. Current Neuropharmacology. 14: 41-7. PMID 26813121  0.6
2016 Fagone P, Mangano K, Di Marco R, Touil-Boukoffa C, Chikovan T, Signorelli S, Lombardo GA, Patti F, Mammana S, Nicoletti F. Expression of DNA methylation genes in secondary progressive multiple sclerosis. Journal of Neuroimmunology. 290: 66-9. PMID 26711572 DOI: 10.1016/j.jneuroim.2015.11.018  0.6
2016 Matriscianoa F, Panaccione I, Grayson DR, Nicoletti F, Guidotti A. Metabotropic glutamate 2/3 receptors and epigenetic modifications in psychotic disorders: A review Current Neuropharmacology. 14: 41-47.  0.6
2015 Fazio F, Lionetto L, Curto M, Iacovelli L, Cavallari M, Zappulla C, Ulivieri M, Napoletano F, Capi M, Corigliano V, Scaccianoce S, Caruso A, Miele J, De Fusco A, Di Menna L, ... ... Nicoletti F, et al. Xanthurenic Acid Activates mGlu2/3 Metabotropic Glutamate Receptors and is a Potential Trait Marker for Schizophrenia. Scientific Reports. 5: 17799. PMID 26643205 DOI: 10.1038/srep17799  0.6
2015 Fagone P, Nicoletti F, Vecchio GM, Parenti R, Magro G. Cyclin D1 in pediatric neuroblastic tumors: A microarray analysis. Acta Histochemica. 117: 820-3. PMID 26510683 DOI: 10.1016/j.acthis.2015.10.002  0.6
2015 Fagone P, Nicoletti F, Salvatorelli L, Musumeci G, Magro G. Cyclin D1 and Ewing's sarcoma/PNET: A microarray analysis. Acta Histochemica. 117: 824-8. PMID 26363896 DOI: 10.1016/j.acthis.2015.08.006  0.6
2015 Giuffrida ML, Tomasello MF, Pandini G, Caraci F, Battaglia G, Busceti C, Di Pietro P, Pappalardo G, Attanasio F, Chiechio S, Bagnoli S, Nacmias B, Sorbi S, Vigneri R, Rizzarelli E, ... Nicoletti F, et al. Monomeric ß-amyloid interacts with type-1 insulin-like growth factor receptors to provide energy supply to neurons. Frontiers in Cellular Neuroscience. 9: 297. PMID 26300732 DOI: 10.3389/fncel.2015.00297  0.6
2015 Mairesse J, Gatta E, Reynaert ML, Marrocco J, Morley-Fletcher S, Soichot M, Deruyter L, Camp GV, Bouwalerh H, Fagioli F, Pittaluga A, Allorge D, Nicoletti F, Maccari S. Activation of presynaptic oxytocin receptors enhances glutamate release in the ventral hippocampus of prenatally restraint stressed rats. Psychoneuroendocrinology. 62: 36-46. PMID 26231445 DOI: 10.1016/j.psyneuen.2015.07.005  0.4
2015 Donia M, Andersen R, Kjeldsen JW, Fagone P, Munir S, Nicoletti F, Andersen MH, Thor Straten P, Svane IM. Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4+ T- Cells, Which Dampen CD8+ T-cell Antitumor Reactivity. Cancer Research. 75: 3747-59. PMID 26183926 DOI: 10.1158/0008-5472.CAN-14-2956  0.6
2015 Fagone P, Mangano K, Mammana S, Pesce A, Pesce A, Caltabiano R, Giorlandino A, Portale TR, Cavalli E, Lombardo GA, Coco M, Puleo S, Nicoletti F. Identification of novel targets for the diagnosis and treatment of liver fibrosis. International Journal of Molecular Medicine. 36: 747-52. PMID 26135677 DOI: 10.3892/ijmm.2015.2264  0.6
2015 D'Amore V, Von Randow C, Nicoletti F, Ngomba RT, Van Luijtelaar G. Anti-absence activity of mGlu1 and mGlu5 receptor enhancers and their interaction with a GABA reuptake inhibitor: Effect of local infusions in the somatosensory cortex and thalamus Epilepsia. 56: 1141-1151. PMID 26040777 DOI: 10.1111/epi.13024  0.6
2015 Reynaert ML, Marrocco J, Mairesse J, Lionetto L, Simmaco M, Deruyter L, Allorge D, Moles A, Pittaluga A, Maccari S, Morley-Fletcher S, Van Camp G, Nicoletti F. Hedonic sensitivity to natural rewards is affected by prenatal stress in a sex-dependent manner. Addiction Biology. PMID 26011513 DOI: 10.1111/adb.12270  0.4
2015 Rapinesi C, Kotzalidis GD, Curto M, Serata D, Ferri VR, Scatena P, Carbonetti P, Napoletano F, Miele J, Scaccianoce S, Del Casale A, Nicoletti F, Angeletti G, Girardi P. Electroconvulsive therapy improves clinical manifestations of treatment-resistant depression without changing serum BDNF levels. Psychiatry Research. 227: 171-8. PMID 25910420 DOI: 10.1016/j.psychres.2015.04.009  0.6
2015 Fagone P, Mangano K, Quattrocchi C, Cavalli E, Mammana S, Lombardo GA, Pennisi V, Zocca MB, He M, Al-Abed Y, Nicoletti F. Effects of NO-Hybridization on the Immunomodulatory Properties of the HIV Protease Inhibitors Lopinavir and Ritonavir. Basic & Clinical Pharmacology & Toxicology. PMID 25903922 DOI: 10.1111/bcpt.12414  0.6
2015 Truini A, Piroso S, Pasquale E, Notartomaso S, Di Stefano G, Lattanzi R, Battaglia G, Nicoletti F, Cruccu G. N-acetyl-cysteine, a drug that enhances the endogenous activation of group-II metabotropic glutamate receptors, inhibits nociceptive transmission in humans. Molecular Pain. 11: 14. PMID 25889381 DOI: 10.1186/s12990-015-0009-2  0.6
2015 Reynaert ML, Marrocco J, Gatta E, Mairesse J, Van Camp G, Fagioli F, Maccari S, Nicoletti F, Morley-Fletcher S. A self-medication hypothesis for increased vulnerability to drug abuse in prenatally restraint stressed rats. Advances in Neurobiology. 10: 101-20. PMID 25287538 DOI: 10.1007/978-1-4939-1372-5_6  0.4
2015 Mairesse J, Van Camp G, Gatta E, Marrocco J, Reynaert ML, Consolazione M, Morley-Fletcher S, Nicoletti F, Maccari S. Sleep in prenatally restraint stressed rats, a model of mixed anxiety-depressive disorder. Advances in Neurobiology. 10: 27-44. PMID 25287534 DOI: 10.1007/978-1-4939-1372-5_2  0.4
2014 Bhouri M, Farrow PA, Motee A, Yan X, Battaglia G, Di Menna L, Riozzi B, Nicoletti F, Fitzjohn SM, Bashir ZI. mGlu1 receptor-induced LTD of NMDA receptor transmission selectively at Schaffer collateral-CA1 synapses mediates metaplasticity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 12223-9. PMID 25186764 DOI: 10.1523/JNEUROSCI.0753-14.2014  0.6
2014 Orlando R, Borro M, Motolese M, Molinaro G, Scaccianoce S, Caruso A, di Nuzzo L, Caraci F, Matrisciano F, Pittaluga A, Mairesse J, Simmaco M, Nisticò R, Monn JA, Nicoletti F. Levels of the Rab GDP dissociation inhibitor (GDI) are altered in the prenatal restrain stress mouse model of schizophrenia and are differentially regulated by the mGlu2/3 receptor agonists, LY379268 and LY354740. Neuropharmacology. 86: 133-44. PMID 25063582 DOI: 10.1016/j.neuropharm.2014.07.009  0.6
2014 McCubrey JA, Steelman LS, Bertrand FE, Davis NM, Sokolosky M, Abrams SL, Montalto G, D'Assoro AB, Libra M, Nicoletti F, Maestro R, Basecke J, Rakus D, Gizak A, Demidenko ZN, et al. GSK-3 as potential target for therapeutic intervention in cancer. Oncotarget. 5: 2881-911. PMID 24931005 DOI: 10.18632/oncotarget.2037  0.6
2014 McCubrey JA, Davis NM, Abrams SL, Montalto G, Cervello M, Libra M, Nicoletti F, D'Assoro AB, Cocco L, Martelli AM, Steelman LS. Targeting breast cancer initiating cells: advances in breast cancer research and therapy. Advances in Biological Regulation. 56: 81-107. PMID 24913694 DOI: 10.1016/j.jbior.2014.05.003  0.6
2014 di Nuzzo L, Orlando R, Nasca C, Nicoletti F. Molecular pharmacodynamics of new oral drugs used in the treatment of multiple sclerosis. Drug Design, Development and Therapy. 8: 555-68. PMID 24876766 DOI: 10.2147/DDDT.S52428  0.6
2014 Pignatelli M, Piccinin S, Molinaro G, Di Menna L, Riozzi B, Cannella M, Motolese M, Vetere G, Catania MV, Battaglia G, Nicoletti F, Nisticò R, Bruno V. Changes in mGlu5 receptor-dependent synaptic plasticity and coupling to homer proteins in the hippocampus of Ube3A hemizygous mice modeling angelman syndrome. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 4558-66. PMID 24672001 DOI: 10.1523/JNEUROSCI.1846-13.2014  0.6
2014 Sani G, Kotzalidis GD, Panaccione I, Simonetti A, De Chiara L, Del Casale A, Ambrosi E, Napoletano F, Janiri D, Danese E, Girardi N, Rapinesi C, Serata D, Manfredi G, Koukopoulos AE, ... ... Nicoletti F, et al. Low-dose acetazolamide in the treatment of premenstrual dysphoric disorder: a case series. Psychiatry Investigation. 11: 95-101. PMID 24605130 DOI: 10.4306/pi.2014.11.1.95  0.6
2014 D'Antoni S, Spatuzza M, Bonaccorso CM, Musumeci SA, Ciranna L, Nicoletti F, Huber KM, Catania MV. Dysregulation of group-I metabotropic glutamate (mGlu) receptor mediated signalling in disorders associated with Intellectual Disability and Autism. Neuroscience and Biobehavioral Reviews. 46: 228-41. PMID 24548786 DOI: 10.1016/j.neubiorev.2014.02.003  0.6
2014 Marrocco J, Reynaert ML, Gatta E, Gabriel C, Mocaër E, Di Prisco S, Merega E, Pittaluga A, Nicoletti F, Maccari S, Morley-Fletcher S, Mairesse J. The effects of antidepressant treatment in prenatally stressed rats support the glutamatergic hypothesis of stress-related disorders. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 2015-24. PMID 24501344 DOI: 10.1523/JNEUROSCI.4131-13.2014  0.6
2014 Nisticò R, Mori F, Feligioni M, Nicoletti F, Centonze D. Synaptic plasticity in multiple sclerosis and in experimental autoimmune encephalomyelitis. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 369: 20130162. PMID 24298163 DOI: 10.1098/rstb.2013.0162  0.6
2014 McCubrey JA, Davis NM, Abrams SL, Montalto G, Cervello M, Basecke J, Libra M, Nicoletti F, Cocco L, Martelli AM, Steelman LS. Diverse roles of GSK-3: tumor promoter-tumor suppressor, target in cancer therapy. Advances in Biological Regulation. 54: 176-96. PMID 24169510 DOI: 10.1016/j.jbior.2013.09.013  0.6
2014 Mori F, Nisticò R, Mandolesi G, Piccinin S, Mango D, Kusayanagi H, Berretta N, Bergami A, Gentile A, Musella A, Nicoletti CG, Nicoletti F, Buttari F, Mercuri NB, Martino G, et al. Interleukin-1β promotes long-term potentiation in patients with multiple sclerosis. Neuromolecular Medicine. 16: 38-51. PMID 23892937 DOI: 10.1007/s12017-013-8249-7  0.6
2013 Panaccione I, Napoletano F, Forte AM, Kotzalidis GD, Del Casale A, Rapinesi C, Brugnoli C, Serata D, Caccia F, Cuomo I, Ambrosi E, Simonetti A, Savoja V, De Chiara L, Danese E, ... ... Nicoletti F, et al. Neurodevelopment in schizophrenia: the role of the wnt pathways. Current Neuropharmacology. 11: 535-58. PMID 24403877 DOI: 10.2174/1570159X113119990037  0.6
2013 Di Pardo A, Alberti S, Maglione V, Amico E, Cortes EP, Elifani F, Battaglia G, Busceti CL, Nicoletti F, Vonsattel JP, Squitieri F. Changes of peripheral TGF-β1 depend on monocytes-derived macrophages in Huntington disease. Molecular Brain. 6: 55. PMID 24330808 DOI: 10.1186/1756-6606-6-55  0.6
2013 Novakovic D, Feligioni M, Scaccianoce S, Caruso A, Piccinin S, Schepisi C, Errico F, Mercuri NB, Nicoletti F, Nisticò R. Profile of gantenerumab and its potential in the treatment of Alzheimer's disease. Drug Design, Development and Therapy. 7: 1359-64. PMID 24255592 DOI: 10.2147/DDDT.S53401  0.6
2013 Jakkamsetti V, Tsai NP, Gross C, Molinaro G, Collins KA, Nicoletti F, Wang KH, Osten P, Bassell GJ, Gibson JR, Huber KM. Experience-induced Arc/Arg3.1 primes CA1 pyramidal neurons for metabotropic glutamate receptor-dependent long-term synaptic depression. Neuron. 80: 72-9. PMID 24094104 DOI: 10.1016/j.neuron.2013.07.020  0.6
2013 Bosco P, Ferri R, Salluzzo MG, Castellano S, Signorelli M, Nicoletti F, Nuovo SD, Drago F, Caraci F. Role of the Transforming-Growth-Factor-β1 Gene in Late-Onset Alzheimer's Disease: Implications for the Treatment. Current Genomics. 14: 147-56. PMID 24082824 DOI: 10.2174/1389202911314020007  0.6
2013 Marrocco J, Mairesse J, Bucci D, Lionetto L, Battaglia G, Consolazione M, Ravasi L, Simmaco M, Morley-Fletcher S, Maccari S, Nicoletti F. Early life stress causes refractoriness to haloperidol-induced catalepsy. Molecular Pharmacology. 84: 244-51. PMID 23716620 DOI: 10.1124/mol.113.085530  0.6
2013 Degos V, Peineau S, Nijboer C, Kaindl AM, Sigaut S, Favrais G, Plaisant F, Teissier N, Gouadon E, Lombet A, Saliba E, Collingridge GL, Maze M, Nicoletti F, Heijnen C, et al. G protein-coupled receptor kinase 2 and group I metabotropic glutamate receptors mediate inflammation-induced sensitization to excitotoxic neurodegeneration. Annals of Neurology. 73: 667-78. PMID 23494575 DOI: 10.1002/ana.23868  0.6
2013 Pignatelli M, Feligioni M, Piccinin S, Molinaro G, Nicoletti F, Nisticò R. Synaptic plasticity as a therapeutic target in the treatment of autism-related single-gene disorders. Current Pharmaceutical Design. 19: 6480-90. PMID 23432715 DOI: 10.2174/1381612811319360008  0.6
2013 Nasca C, Xenos D, Barone Y, Caruso A, Scaccianoce S, Matrisciano F, Battaglia G, Mathé AA, Pittaluga A, Lionetto L, Simmaco M, Nicoletti F. L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors. Proceedings of the National Academy of Sciences of the United States of America. 110: 4804-9. PMID 23382250 DOI: 10.1073/pnas.1216100110  0.56
2013 Panaccione I, King R, Molinaro G, Riozzi B, Battaglia G, Nicoletti F, Bashir ZI. Constitutively active group I mGlu receptors and PKMzeta regulate synaptic transmission in developing perirhinal cortex. Neuropharmacology. 66: 143-50. PMID 23357951 DOI: 10.1016/j.neuropharm.2012.03.010  0.6
2013 Nisticò R, Mango D, Mandolesi G, Piccinin S, Berretta N, Pignatelli M, Feligioni M, Musella A, Gentile A, Mori F, Bernardi G, Nicoletti F, Mercuri NB, Centonze D. Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis. Plos One. 8: e54666. PMID 23355887 DOI: 10.1371/journal.pone.0054666  0.6
2013 Nasca C, Orlando R, Marchiafava M, Boldrini P, Battaglia G, Scaccianoce S, Matrisciano F, Pittaluga A, Nicoletti F. Exposure to predator odor and resulting anxiety enhances the expression of the α2 δ subunit of voltage-sensitive calcium channels in the amygdala. Journal of Neurochemistry. 125: 649-56. PMID 22849384 DOI: 10.1111/j.1471-4159.2012.07895.x  0.6
2013 Pignatelli M, Vollmayr B, Richter SH, Middei S, Matrisciano F, Molinaro G, Nasca C, Battaglia G, Ammassari-Teule M, Feligioni M, Nisticò R, Nicoletti F, Gass P. Enhanced mGlu5-receptor dependent long-term depression at the Schaffer collateral-CA1 synapse of congenitally learned helpless rats. Neuropharmacology. 66: 339-47. PMID 22709946 DOI: 10.1016/j.neuropharm.2012.05.046  0.6
2012 Sani G, Napoletano F, Forte AM, Kotzalidis GD, Panaccione I, Porfiri GM, Simonetti A, Caloro M, Girardi N, Telesforo CL, Serra G, Romano S, Manfredi G, Savoja V, Tamorri SM, ... ... Nicoletti F, et al. The wnt pathway in mood disorders. Current Neuropharmacology. 10: 239-53. PMID 23449817 DOI: 10.2174/157015912803217279  0.6
2012 Marrocco J, Mairesse J, Ngomba RT, Silletti V, Van Camp G, Bouwalerh H, Summa M, Pittaluga A, Nicoletti F, Maccari S, Morley-Fletcher S. Anxiety-like behavior of prenatally stressed rats is associated with a selective reduction of glutamate release in the ventral hippocampus. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 17143-54. PMID 23197707 DOI: 10.1523/JNEUROSCI.1040-12.2012  0.6
2012 Busceti CL, Bucci D, Molinaro G, Di Pietro P, Zangrandi L, Gradini R, Moratalla R, Battaglia G, Bruno V, Nicoletti F, Fornai F. Lack or inhibition of dopaminergic stimulation induces a development increase of striatal tyrosine hydroxylase-positive interneurons. Plos One. 7: e44025. PMID 23028485 DOI: 10.1371/journal.pone.0044025  0.6
2012 Giuffrida ML, Tomasello F, Caraci F, Chiechio S, Nicoletti F, Copani A. Beta-amyloid monomer and insulin/IGF-1 signaling in Alzheimer's disease. Molecular Neurobiology. 46: 605-13. PMID 22886436 DOI: 10.1007/s12035-012-8313-6  0.6
2012 Matrisciano F, Tueting P, Maccari S, Nicoletti F, Guidotti A. Pharmacological activation of group-II metabotropic glutamate receptors corrects a schizophrenia-like phenotype induced by prenatal stress in mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 929-38. PMID 22089319 DOI: 10.1038/npp.2011.274  0.6
2012 Chiechio S, Nicoletti F. Metabotropic glutamate receptors and the control of chronic pain. Current Opinion in Pharmacology. 12: 28-34. PMID 22040745 DOI: 10.1016/j.coph.2011.10.010  0.6
2011 Maccari S, Nicoletti F. Agomelatine: protecting the CNS from the effects of stress. Cns Neuroscience & Therapeutics. 17: 269-70. PMID 21951364 DOI: 10.1111/j.1755-5949.2010.00174.x  0.6
2011 Di Rosa M, Malaguarnera M, Nicoletti F, Malaguarnera L. Vitamin D3: A helpful immuno-modulator Immunology. 134: 123-139. PMID 21896008 DOI: 10.1111/j.1365-2567.2011.03482.x  0.6
2011 Nicoletti F, Fagone P, Meroni P, McCubrey J, Bendtzen K. MTOR as a multifunctional therapeutic target in HIV infection Drug Discovery Today. 16: 715-721. PMID 21624501 DOI: 10.1016/j.drudis.2011.05.008  0.6
2011 Matrisciano F, Dong E, Gavin DP, Nicoletti F, Guidotti A. Activation of group II metabotropic glutamate receptors promotes DNA demethylation in the mouse brain. Molecular Pharmacology. 80: 174-82. PMID 21505039 DOI: 10.1124/mol.110.070896  0.6
2011 Steelman LS, Martelli AM, Nicoletti F, McCubrey JA. Exploiting p53 status to enhance effectiveness of chemotherapy by lowering associated toxicity. Oncotarget. 2: 109-12. PMID 21487160 DOI: 10.18632/oncotarget.247  0.6
2010 Donia M, McCubrey JA, Bendtzen K, Nicoletti F. Potential use of rapamycin in HIV infection. British Journal of Clinical Pharmacology. 70: 784-93. PMID 21175433 DOI: 10.1111/j.1365-2125.2010.03735.x  0.6
2009 Malaguarnera M, Di Rosa M, Nicoletti F, Malaguarnera L. Molecular mechanisms involved in NAFLD progression Journal of Molecular Medicine. 87: 679-695. PMID 19352614 DOI: 10.1007/s00109-009-0464-1  0.6
2008 Nicoletti F, Collingridge G, Schoepp D. 2008 Eruptions in metabotropic glutamate receptors Neuropharmacology. 55: 391. PMID 18638495 DOI: 10.1016/j.neuropharm.2008.07.003  0.6
2008 Modafferi AM, Diana M, Nicoletti F, Scaccianoce S. Morphine withdrawal increases metabotropic glutamate 2/3 receptors expression in nucleus accumbens. Neuroreport. 19: 911-4. PMID 18520992 DOI: 10.1097/WNR.0b013e3283021cc0  0.6
2007 Chiechio S, Copani A, Gereau RW, Nicoletti F. Acetyl-L-carnitine in neuropathic pain: experimental data. Cns Drugs. 21: 31-8; discussion 45-. PMID 17696591 DOI: 10.2165/00023210-200721001-00005  0.6
2006 Chiechio S, Copani A, Nicoletti F, Gereau RW. L-acetylcarnitine: a proposed therapeutic agent for painful peripheral neuropathies. Current Neuropharmacology. 4: 233-7. PMID 18615142 DOI: 10.2174/157015906778019509  0.6
2006 Gereau RW, Nicoletti F. Editorial: Pain Current Neuropharmacology. 4: 173. DOI: 10.2174/157015906778019491  0.6
2005 Zaccone P, Phillips J, Conget I, Cooke A, Nicoletti F. IL-18 binding protein fusion construct delays the development of diabetes in adoptive transfer and cyclophosphamide-induced diabetes in NOD mouse. Clinical Immunology (Orlando, Fla.). 115: 74-9. PMID 15870024 DOI: 10.1016/j.clim.2004.11.007  0.6
2003 Xiang M, Nicoletti F. The effects of interleukin-6 on the development of autoimmune diabetes in NOD mouse Chinese Pharmacological Bulletin. 19: 917-919.  0.6
2002 Papaccio G, Nicoletti F, Pisanti FA, Galdieri M, Bendtzen K. An imidazoline compound completely counteracts interleukin-1β toxic effects to rat pancreatic islet β cells Molecular Medicine. 8: 536-545. PMID 12456992  0.6
2000 Riedel G, Casabona G, Platt B, Macphail EM, Nicoletti F. Fear conditioning-induced time- and subregion-specific increase in expression of mGlu5 receptor protein in rat hippocampus. Neuropharmacology. 39: 1943-51. PMID 10963738 DOI: 10.1016/S0028-3908(00)00037-X  0.6
2000 Papaccio G, Nicoletti F, Pisanti FA, Bendtzen K, Galdieri M. Prevention of spontaneous autoimmune diabetes in NOD mice by transferring in vitro antigen-pulsed syngeneic dendritic cells Endocrinology. 141: 1500-1505. PMID 10746656 DOI: 10.1210/en.141.4.1500  0.6
1999 Nicoletti F, Patti F, Nicoletti A, L'Episcopo MR, DiMarco R, Bendtzen K, Reggio A. Sodium fusidate in steroid resistant relapses of multiple sclerosis [1] Multiple Sclerosis. 5: 377. PMID 10644161  0.6
1998 Bruno V, Wroblewska B, Wroblewski JT, Fiore L, Nicoletti F. Neuroprotective activity of N-acetylaspartylglutamate in cultured cortical cells. Neuroscience. 85: 751-7. PMID 9639269 DOI: 10.1016/S0306-4522(97)00531-9  0.6
1997 Lunetta M, Mauro MDI, Moli RLE, Nicoletti F. Effect of octreotide on growth hormone, IGF-I, IGFBP-3, glucagon, cortisol and epinephrine response to insulin-induced hypoglycaemia in insulin-dependent diabetic patients Diabetes and Metabolism. 23: 524-527. PMID 9496559  0.6
1997 Lunetta M, Di Mauro M, Le Moli R, Nicoletti F. Effects of octreotide on glycaemic control, glucose disposal, hepatic glucose production and counterregulatory hormones secretion in type 1 and type 2 insulin treated diabetic patients Diabetes Research and Clinical Practice. 38: 81-89. PMID 9483371 DOI: 10.1016/S0168-8227(97)00094-6  0.6
1997 Cocuzza C, Blandino G, Mattina R, Nicoletti F, Nicoletti G. Antibiotic susceptibility of group A streptococci in 2 Italian cities: Milano and Catania Microbial Drug Resistance. 3: 379-384. PMID 9442491  0.6
1996 Nicoletti F, Meroni PL, Bendtzen K. Fusidic acid and insulin-dependent diabetes mellitus Autoimmunity. 24: 187-197. PMID 9020411  0.6
1996 Lunetta M, Di Mauro M, Le Moli R, Nicoletti F. Effect of octreotide on blood glucose and counterregulatory hormones in insulin-dependent diabetic patients: The role of dose and route of administration European Journal of Clinical Pharmacology. 51: 139-144. PMID 8911878 DOI: 10.1007/s002280050174  0.6
1996 Nicoletti F, Bruno V, Copani A, Casabona G, Knöpfel T. Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders? Trends in Neurosciences. 19: 267-71. PMID 8799968 DOI: 10.1016/S0166-2236(96)20019-0  0.6
1993 Aronica E, Nicoletti F, Condorelli DF, Balázs R. Pharmacological characterization of metabotropic glutamate receptors in cultured cerebellar granule cells. Neurochemical Research. 18: 605-12. PMID 8097299 DOI: 10.1007/BF00966938  0.6
1993 Lunetta M, Di Mauro M, Nicoletti F, Mughini L. Effects of naloxone on immunoreactive insulin and C-peptide response to intravenous glucagon in obese women Medical Science Research. 21: 211-212.  0.6
1991 Lunetta M, Di Mauro M, Nicoletti F, Mughini L. Diabetogenic effect of naloxone in subjects with impaired glucose tolerance Medical Science Research. 19: 737-738.  0.6
1988 Nicoletti F, Wroblewski JT, Fadda E, Costa E. Pertussis toxin inhibits signal transduction at a specific metabolotropic glutamate receptor in primary cultures of cerebellar granule cells. Neuropharmacology. 27: 551-6. PMID 2843781 DOI: 10.1016/0028-3908(88)90174-8  0.6
1987 Wroblewski JT, Nicoletti F, Fadda E, Costa E. Phencyclidine is a negative allosteric modulator of signal transduction at two subclasses of excitatory amino acid receptors. Proceedings of the National Academy of Sciences of the United States of America. 84: 5068-72. PMID 3037532  0.6
1987 Nicoletti F, Wroblewski JT, Costa E. Magnesium ions inhibit the stimulation of inositol phospholipid hydrolysis by endogenous excitatory amino acids in primary cultures of cerebellar granule cells. Journal of Neurochemistry. 48: 967-73. PMID 2879893 DOI: 10.1111/j.1471-4159.1987.tb05611.x  0.6
1986 Iadorola MJ, Nicoletti F, Naranjo JR, Putnam F, Costa E. Kindling enhances the stimulation of inositol phospholipid hydrolysis elicited by ibotenic acid in rat hippocampal slices Brain Research. 374: 174-178. PMID 3719324 DOI: 10.1016/0006-8993(86)90407-5  0.44
1986 Nicoletti G, Oliveri S, Cammarata E, Nicoletti F, Tempera G. Microbial infections in the drug addict Giornale Di Batteriologia Virologia Ed Immunologia. 79: 124-143. PMID 3315801  0.6
1986 Nicoletti F, Wroblewski JT, Iadarola MJ, Costa E. Serine-O-phosphate, an endogenous metabolite, inhibits the stimulation of inositol phospholipid hydrolysis elicited by ibotenic acid in rat hippocampal slices. Neuropharmacology. 25: 335-8. PMID 3084992 DOI: 10.1016/0028-3908(86)90262-5  0.6
1986 Nicoletti F, Wroblewski JT, Novelli A, Guidotti A, Costa E. Excitatory amino acid signal transduction in cerebellar cell cultures. Functional Neurology. 1: 345-9. PMID 2886406  0.6
1986 Nicoletti F, Iadarola MJ, Wroblewski JT, Costa E. Excitatory amino acid recognition sites coupled with inositol phospholipid metabolism: developmental changes and interaction with alpha 1-adrenoceptors. Proceedings of the National Academy of Sciences of the United States of America. 83: 1931-5. PMID 2869493  0.6
1985 Wroblewski JT, Nicoletti F, Costa E. Different coupling of excitatory amino acid receptors with Ca2+ channels in primary cultures of cerebellar granule cells. Neuropharmacology. 24: 919-21. PMID 2414684 DOI: 10.1016/0028-3908(85)90046-2  0.44
1985 Novelli A, Nicoletti F, Wroblewski A, Costa E. Membrane inositol phospholipid turnover and cGMP content following stimulation of excitatory amino acid receptors Federation Proceedings. 44.  0.44
Show low-probability matches.